News
I think these stocks stand out from the rest of the ASX 20 pack. The post My top 3 picks in the ASX 20 in June appeared first ...
8h
MOTORVISION plus on MSNPorsche Cayenne vs BMW M4 CSL, luxury meets performanceJoin us in this automotive showdown between the luxurious Porsche Cayenne and the thrilling BMW M4 CSL. Discover their unique ...
We take a look a the CSL stock performance, and consult some analysts on what they think might be a good ride for CSL to ...
Decades into its tenure as a drug seller, CSL Behring has finally dipped its toe into the waters of TV advertising. | Decades ...
CSL Ltd (ASX: CSL)'s bumper share price might make some investors question whether now is a good time to buy. Find out more ...
CSL (ASX:CSL) saw its stock price rise by 3% over the last month, amid important developments and a fluctuating market environment. CSL Vifor's notable progress with the National Institute for Health ...
Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa ...
9d
GlobalData on MSNNICE endorses CSL Vifor’s sparsentan for IgA nephropathy in adultsThe UK's National Institute for Health and Care Excellence (NICE) has issued final draft guidance endorsing the use of CSL ...
We initiate on Carlisle Companies (NYSE:CSL) with a Hold rating and $349 PT. Carlisle Companies is a leading-diversified manufacturer with core segments in construction materials, interconnect ...
Final draft guidance from NICE has backed NHS use of Filspari (sparsentan) for primary immunoglobulin A nephropathy (IgAN), ...
Jarden analyst Steven Wheen maintained a Buy rating on CSL (CMXHF – Research Report) on May 18 and set a price target of A$317.61. The company’s shares closed today at $150.96 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results